111732
论文已发表
注册即可获取德孚的最新动态
IF 收录期刊
- 3.4 Breast Cancer (Dove Med Press)
- 3.2 Clin Epidemiol
- 2.6 Cancer Manag Res
- 2.9 Infect Drug Resist
- 3.7 Clin Interv Aging
- 5.1 Drug Des Dev Ther
- 3.1 Int J Chronic Obstr
- 6.6 Int J Nanomed
- 2.6 Int J Women's Health
- 2.9 Neuropsych Dis Treat
- 2.8 OncoTargets Ther
- 2.0 Patient Prefer Adher
- 2.2 Ther Clin Risk Manag
- 2.5 J Pain Res
- 3.0 Diabet Metab Synd Ob
- 3.2 Psychol Res Behav Ma
- 3.4 Nat Sci Sleep
- 1.8 Pharmgenomics Pers Med
- 2.0 Risk Manag Healthc Policy
- 4.1 J Inflamm Res
- 2.0 Int J Gen Med
- 3.4 J Hepatocell Carcinoma
- 3.0 J Asthma Allergy
- 2.2 Clin Cosmet Investig Dermatol
- 2.4 J Multidiscip Healthc
已发表论文
整合分子诊断揭示免疫功能低下宿主中嗜肺军团菌与真菌合并感染：精准抗菌药物管理的案例研究
Authors Deng Q , Yang Y, Gao S, Lu M, Zhao Y , Wang Z
Received 9 July 2025
Accepted for publication 17 October 2025
Published 27 October 2025 Volume 2025:18 Pages 5549—5556
DOI https://doi.org/10.2147/IDR.S552347
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 2
Editor who approved publication: Dr Hazrat Bilal
Qianyun Deng,1,* Yujing Yang,1,* Siyi Gao,2 Mengdi Lu,1 Yunhu Zhao,1 Zixia Wang1
1Department of Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510000, People’s Republic of China; 2Inspection Section, Luonan County Chinese Medicine Hospital, Luonan, Shangluo, Shaanxi, 726100, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Yunhu Zhao, Email zhaoyunhu@gdph.org.cn Zixia Wang, Email wangzixia@gdph.org.cn
Background: Legionella pneumophila poses significant diagnostic challenges in immunocompromised hosts due to its fastidious growth requirements and nonspecific clinical presentation. Conventional culture methods have limited sensitivity (30– 80%), while molecular diagnostics require multi-platform validation to ensure reliability.
Case Description: A 57-year-old woman with rheumatic heart disease, chronic renal failure, and immunosuppression presented with acute respiratory failure. Initial investigations revealed leukocytosis (19.03× 109/L), hyponatremia (127 mmol/L), elevated procalcitonin (42.55 ng/mL), and bilateral pulmonary infiltrates. Bronchoalveolar lavage fluid (BALF) analysis employed three molecular methods: isothermal amplification for screening (positive for L. pneumophila on ICU admission), digital PCR (dPCR, 4,455 copies/mL after 10-fold dilution) reconfirmed L. pneumophila infection, and metagenomic next-generation sequencing (mNGS; 384,661 Legionella reads alongside 3,474 Candida glabrata reads). Subsequent fungal β-D-glucan testing (674.8 pg/mL) and culture validated Candida glabrata coinfection. Antimicrobial therapy from targeted moxifloxacin/azithromycin to co-infection therapy with carbapenem escalated from Imipenem-cilastatin to sulbactam/cefoperazone for suspected gram-negative coinfection and fluconazole escalated to amphotericin B for resistant candidiasis guided by CRP/PCT trends.
Conclusion: Integrated molecular diagnostics enable rapid pathogen identification in critically ill immunocompromised hosts. Multi-platform verification (isothermal amplification/dPCR/mNGS) overcomes technical limitations of single methods, while serial biomarker monitoring optimizes antimicrobial stewardship for mixed infections.
Keywords: Legionella pneumophila, metagenomic next-generation sequencing, digital PCR, immunocompromised host, mixed infection
1Department of Laboratory Medicine, Guangdong Provincial People’s Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, Guangdong, 510000, People’s Republic of China; 2Inspection Section, Luonan County Chinese Medicine Hospital, Luonan, Shangluo, Shaanxi, 726100, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Yunhu Zhao, Email zhaoyunhu@gdph.org.cn Zixia Wang, Email wangzixia@gdph.org.cn
Background: Legionella pneumophila poses significant diagnostic challenges in immunocompromised hosts due to its fastidious growth requirements and nonspecific clinical presentation. Conventional culture methods have limited sensitivity (30– 80%), while molecular diagnostics require multi-platform validation to ensure reliability.
Case Description: A 57-year-old woman with rheumatic heart disease, chronic renal failure, and immunosuppression presented with acute respiratory failure. Initial investigations revealed leukocytosis (19.03× 109/L), hyponatremia (127 mmol/L), elevated procalcitonin (42.55 ng/mL), and bilateral pulmonary infiltrates. Bronchoalveolar lavage fluid (BALF) analysis employed three molecular methods: isothermal amplification for screening (positive for L. pneumophila on ICU admission), digital PCR (dPCR, 4,455 copies/mL after 10-fold dilution) reconfirmed L. pneumophila infection, and metagenomic next-generation sequencing (mNGS; 384,661 Legionella reads alongside 3,474 Candida glabrata reads). Subsequent fungal β-D-glucan testing (674.8 pg/mL) and culture validated Candida glabrata coinfection. Antimicrobial therapy from targeted moxifloxacin/azithromycin to co-infection therapy with carbapenem escalated from Imipenem-cilastatin to sulbactam/cefoperazone for suspected gram-negative coinfection and fluconazole escalated to amphotericin B for resistant candidiasis guided by CRP/PCT trends.
Conclusion: Integrated molecular diagnostics enable rapid pathogen identification in critically ill immunocompromised hosts. Multi-platform verification (isothermal amplification/dPCR/mNGS) overcomes technical limitations of single methods, while serial biomarker monitoring optimizes antimicrobial stewardship for mixed infections.
Keywords: Legionella pneumophila, metagenomic next-generation sequencing, digital PCR, immunocompromised host, mixed infection